1106 related articles for article (PubMed ID: 20135355)
1. Clinicopathological prognostic factors after hepatectomy for patients with mass-forming type intrahepatic cholangiocarcinoma: relevance of the lymphatic invasion index.
Shirabe K; Mano Y; Taketomi A; Soejima Y; Uchiyama H; Aishima S; Kayashima H; Ninomiya M; Maehara Y
Ann Surg Oncol; 2010 Jul; 17(7):1816-22. PubMed ID: 20135355
[TBL] [Abstract][Full Text] [Related]
2. Serosal invasion in TNM staging of mass-forming intrahepatic cholangiocarcinoma.
Uenishi T; Yamazaki O; Yamamoto T; Hirohashi K; Tanaka H; Tanaka S; Hai S; Kubo S
J Hepatobiliary Pancreat Surg; 2005; 12(6):479-83. PubMed ID: 16365823
[TBL] [Abstract][Full Text] [Related]
3. Prognostic factors of intrahepatic cholangiocarcinoma after hepatic resection: univariate and multivariate analysis.
Hanazaki K; Kajikawa S; Shimozawa N; Shimada K; Hiraguri M; Koide N; Adachi W; Amano J
Hepatogastroenterology; 2002; 49(44):311-6. PubMed ID: 11995440
[TBL] [Abstract][Full Text] [Related]
4. The impact of surgical treatment and poor prognostic factors for patients with intrahepatic cholangiocarcinoma: retrospective analysis of 60 patients.
Yamashita Y; Taketomi A; Morita K; Fukuhara T; Ueda S; Sanefuji K; Iguchi T; Kayashima H; Sugimachi K; Maehara Y
Anticancer Res; 2008; 28(4C):2353-9. PubMed ID: 18751418
[TBL] [Abstract][Full Text] [Related]
5. Survival analysis of intrahepatic cholangiocarcinoma after resection.
Cho SY; Park SJ; Kim SH; Han SS; Kim YK; Lee KW; Lee SA; Hong EK; Lee WJ; Woo SM
Ann Surg Oncol; 2010 Jul; 17(7):1823-30. PubMed ID: 20165987
[TBL] [Abstract][Full Text] [Related]
6. Hepatopancreatoduodenectomy could be allowed for patients with advanced intrahepatic cholangiocarcinoma.
Urahashi T; Yamamoto M; Ohtsubo T; Katsuragawa H; Katagiri S; Takasaki K
Hepatogastroenterology; 2007 Mar; 54(74):346-9. PubMed ID: 17523271
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathologic features in patients with long-term survival following resection for intrahepatic cholangiocarcinoma.
Uenishi T; Hirohashi K; Kubo S; Yamamoto T; Yamazaki O; Shuto T; Tanaka H; Kinoshita H
Hepatogastroenterology; 2003; 50(52):1069-72. PubMed ID: 12845984
[TBL] [Abstract][Full Text] [Related]
8. Surgical treatment of mass-forming intrahepatic cholangiocarcinoma: an 11-year Western single-center experience in 107 patients.
Yedibela S; Demir R; Zhang W; Meyer T; Hohenberger W; Schönleben F
Ann Surg Oncol; 2009 Feb; 16(2):404-12. PubMed ID: 19037702
[TBL] [Abstract][Full Text] [Related]
9. [Biopathological characteristics of hilar cholangiocarcinoma and the clinical significance].
Yu WL; Zhang YJ; Dong H; Yu H; Xian ZH; Wu MC; Cong WM
Zhonghua Wai Ke Za Zhi; 2009 Aug; 47(15):1162-6. PubMed ID: 20021908
[TBL] [Abstract][Full Text] [Related]
10. Results of surgical treatment for intrahepatic cholangiocarcinoma and clinicopathological factors influencing survival.
Ohtsuka M; Ito H; Kimura F; Shimizu H; Togawa A; Yoshidome H; Miyazaki M
Br J Surg; 2002 Dec; 89(12):1525-31. PubMed ID: 12445060
[TBL] [Abstract][Full Text] [Related]
11. Macroscopic types of intrahepatic cholangiocarcinoma: clinicopathologic features and surgical outcomes.
Hirohashi K; Uenishi T; Kubo S; Yamamoto T; Tanaka H; Shuto T; Kinoshita H
Hepatogastroenterology; 2002; 49(44):326-9. PubMed ID: 11995443
[TBL] [Abstract][Full Text] [Related]
12. Retrospective analysis of histopathologic prognostic factors after hepatectomy for intrahepatic cholangiocarcinoma.
Jiang BG; Sun LL; Yu WL; Tang ZH; Zong M; Zhang YJ
Cancer J; 2009; 15(3):257-61. PubMed ID: 19556914
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological factors predicting outcome after resection of mass-forming intrahepatic cholangiocarcinoma.
Uenishi T; Hirohashi K; Kubo S; Yamamoto T; Yamazaki O; Kinoshita H
Br J Surg; 2001 Jul; 88(7):969-74. PubMed ID: 11442529
[TBL] [Abstract][Full Text] [Related]
14. Histologic bile duct invasion by a mass-forming intrahepatic cholangiocarcinoma.
Hirohashi K; Uenishi T; Kubo S; Yamamoto T; Tanaka H; Shuto T; Yamasaki O; Horii K; Kinoshita H
J Hepatobiliary Pancreat Surg; 2002; 9(2):233-6. PubMed ID: 12140612
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of lymph node metastasis and surgical margin status for distal cholangiocarcinoma.
Murakami Y; Uemura K; Hayashidani Y; Sudo T; Hashimoto Y; Ohge H; Sueda T
J Surg Oncol; 2007 Mar; 95(3):207-12. PubMed ID: 17278119
[TBL] [Abstract][Full Text] [Related]
16. Clinical impact of the surgical margin status in hepatectomy for solitary mass-forming type intrahepatic cholangiocarcinoma without lymph node metastases.
Shimada K; Sano T; Sakamoto Y; Esaki M; Kosuge T; Ojima H
J Surg Oncol; 2007 Aug; 96(2):160-5. PubMed ID: 17443744
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of intrahepatic lymphatic invasion in patients with hepatic resection due to metastases from colorectal carcinoma.
Sasaki A; Aramaki M; Kawano K; Yasuda K; Inomata M; Kitano S
Cancer; 2002 Jul; 95(1):105-11. PubMed ID: 12115323
[TBL] [Abstract][Full Text] [Related]
18. Hepatic resection for intrahepatic cholangiocarcinoma: relation to gross tumor morphology.
Itamoto T; Asahara T; Katayama K; Nakahara H; Fukuda T; Yano M; Hino H; Nakahara M; Dohi K; Shimamoto F
Hepatogastroenterology; 2001; 48(40):1129-33. PubMed ID: 11490816
[TBL] [Abstract][Full Text] [Related]
19. Surgery for periductal infiltrating type intrahepatic cholangiocarcinoma without hilar invasion provides a better outcome than for mass-forming type intrahepatic cholangiocarcinoma without hilar invasion.
Imai K; Yamamoto M; Ariizumi S
Hepatogastroenterology; 2010; 57(104):1333-6. PubMed ID: 21443080
[TBL] [Abstract][Full Text] [Related]
20. Hepatectomy with portal vein resection for hilar cholangiocarcinoma: audit of 52 consecutive cases.
Ebata T; Nagino M; Kamiya J; Uesaka K; Nagasaka T; Nimura Y
Ann Surg; 2003 Nov; 238(5):720-7. PubMed ID: 14578735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
